Hilde Windels

Hilde Windels is the founder of Antelope Dx BV, founded in 2019, serving as Chief Executive Officer & Director.
Current jobs include Executive Chairman & Co-Chief Executive Officer at MyCartis NV since 2015, Chairman at Celyad Oncology SA since 2022, Independent Non-Executive Director at MDxHealth SA since 2017, Independent Director at Gimv NV, Director at Microphyt SA, Director at Windels Hilde BV since 2001, and Independent Director at PHAXIAM Therapeutics SA since 2023.
Former jobs include Co-Chief Executive Officer at Biocartis SA from 2015 to 2017, Chief Financial Officer & Director at deVGen NV from 2001 to 2008, Independent Director at Ablynx NV from 2017 to 2018, Director at Vlaams Instituut voor Biotechnologie - Flanders Institute from 2013 to 2019, Independent Director at ERYTech Pharma SA, Director at FlandersBio vzw from 2011 to 2014, Executive Director at Biocartis Group NV from 2017 to 2019, Manager at ING Bank NV, Amsterdam, succursale de Lancy, Chief Financial Officer at SEPS Pharma NV, and Chief Financial Officer at TiGenix NV.
Education includes a graduate degree from Katholieke Universiteit Leuven in 1987.